Bridging the Gap: Soft Tissue Pathology for Clinicians
Soft tissue tumors (sarcomas and their benign counterparts) represent a diagnostic nightmare. They are rare, morphologically overlapping, and notoriously difficult to classify even for experienced surgical pathologists. However, the treating surgeon or oncologist cannot wait for academic certainty; they need actionable data to plan radical resections or neoadjuvant therapies. Soft Tissue Pathology for Clinicians is the definitive, fiercely practical manual designed to bridge the communication gap between the pathology laboratory and the surgical oncology suite. This volume provides the exact blueprints required by clinicians to understand the pathology report, ask the right questions, and integrate complex molecular data into surgical planning.
Mastering the Pathology Report
The core philosophy of this text is translational clarity. The authors aggressively detail the most common and the most dangerous soft tissue lesions, dictating exactly what a diagnosis of “atypical lipomatous tumor” versus “dedifferentiated liposarcoma” actually means for the patient’s prognosis and surgical margins. It provides the crucial framework for understanding the limitations of core needle biopsies in these heterogeneous tumors, guiding clinicians on when to demand a larger incisional biopsy.
Navigating Immunohistochemistry and Molecular Genetics
The book provides a masterclass in modern sarcoma diagnostics. It dictates the exact clinical pathways for interpreting the dizzying array of immunohistochemical (IHC) markers and specific genetic translocations (like the synovial sarcoma SS18-SSX fusion) that define modern WHO classifications. It provides exhaustive, clear explanations of how these genetic markers are not just diagnostic, but increasingly serve as targets for novel tyrosine kinase inhibitors.
Frequently Asked Questions (FAQs)
Is this a textbook for learning how to read slides?
No, it is specifically designed for the *consumer* of the pathology report—the surgeon and oncologist—focusing on the clinical implications of the pathologist’s findings rather than the microscopic details.
Who is the primary audience?
It is the absolute, mandatory clinical guide for Surgical Oncologists, Orthopedic Oncologists, Medical Oncologists, and Radiation Oncologists.
